These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20486278)

  • 1. Formation of the cytotoxic aldehyde acrolein during in vitro degradation of cyclophosphamide.
    Alarcon RA; Meienhofer J
    Nat New Biol; 1971 Oct; 233(42):250-2. PubMed ID: 20486278
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes.
    Bohnenstengel F; Eichelbaum M; Golbs E; Kroemer HK
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):163-8. PubMed ID: 9187396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
    Alarcon RA; Meienhofer J; Atherton E
    Cancer Res; 1972 Nov; 32(11):2519-23. PubMed ID: 5082597
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes.
    Baumann F; Schmidt R; Teichert J; Preiss R
    J Clin Lab Anal; 2005; 19(3):103-9. PubMed ID: 15900571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical fluorescence detection of acrolein in human plasma via a two-step tethering approach.
    Togashi M; Terai T; Kojima H; Hanaoka K; Igarashi K; Hirata Y; Urano Y; Nagano T
    Chem Commun (Camb); 2014 Dec; 50(95):14946-8. PubMed ID: 24944098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.
    Alarcon RA
    Cancer Treat Rep; 1976 Apr; 60(4):327-35. PubMed ID: 1277208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of allyl alcohol into acrolein by rat liver.
    Serafini-Cessi F
    Biochem J; 1972 Aug; 128(5):1103-7. PubMed ID: 4404964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.
    MacAllister SL; Martin-Brisac N; Lau V; Yang K; O'Brien PJ
    Chem Biol Interact; 2013 Feb; 202(1-3):259-66. PubMed ID: 23220588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxidation of acrolein by rat liver aldehyde dehydrogenases. Relation to allyl alcohol hepatotoxicity.
    Rikans LE
    Drug Metab Dispos; 1987; 15(3):356-62. PubMed ID: 2886311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
    Marinello AJ; Gurtoo HL; Struck RF; Paul B
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of alpha, beta-unsaturated aldehydes on hepatic thiols and thiol-containing enzymes.
    Cooper KO; Witz G; Witmer C
    Fundam Appl Toxicol; 1992 Oct; 19(3):343-9. PubMed ID: 1334014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biotransformation of allyl alcohol and acrolein in rat liver and lung preparations.
    Patel JM; Wood JC; Leibman KC
    Drug Metab Dispos; 1980; 8(5):305-8. PubMed ID: 6107226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified guanines representing O(6)-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde: synthesis, stability, and ab initio studies.
    Balu N; Gamcsik MP; Colvin ME; Colvin OM; Dolan ME; Ludeman SM
    Chem Res Toxicol; 2002 Mar; 15(3):380-7. PubMed ID: 11896686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclophosphamide and ifosfamide on neuroblastoma cells before and after activation by microsomes.
    Meyer T; Wierse G; Weinrebe W; Treuner J; Niethammer D; Bruchelt G
    Anticancer Res; 1997; 17(2A):981-6. PubMed ID: 9137438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide.
    Moon KY; Kwon CH
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1673-8. PubMed ID: 9873412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trofosfamide metabolism in different species--ifosfamide is the predominant metabolite.
    Boos J; Küpker F; Blaschke G; Jürgens H
    Cancer Chemother Pharmacol; 1993; 33(1):71-6. PubMed ID: 8269592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of microsomal cytochrome c reductase activity by a series of alpha, beta-unsaturated aldehydes.
    Cooper KO; Witmer CM; Witz G
    Biochem Pharmacol; 1987 Mar; 36(5):627-31. PubMed ID: 3103627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cyclophosphamide metabolites with membrane proteins: an in vitro study with rabbit liver microsomes and human red blood cells. Effect of thiols.
    Wildenauer DB; Oehlmann CE
    Biochem Pharmacol; 1982 Nov; 31(22):3535-41. PubMed ID: 7181935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.